相似文献
1
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
Cancer Gene Ther. 2009 Oct;16(10):794-805. doi: 10.1038/cgt.2009.23. Epub 2009 Apr 10.
2
YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
Int J Cancer. 2011 Sep 1;129(5):1265-76. doi: 10.1002/ijc.25783. Epub 2011 Jan 6.
3
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
Br J Cancer. 2009 Apr 7;100(7):1154-64. doi: 10.1038/sj.bjc.6604969. Epub 2009 Mar 10.
4
A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis.
Tumour Biol. 2013 Apr;34(2):1263-71. doi: 10.1007/s13277-013-0701-7. Epub 2013 Feb 21.
5
The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.
Stem Cells Transl Med. 2013 Sep;2(9):655-66. doi: 10.5966/sctm.2013-0039. Epub 2013 Aug 7.
6
Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
Stem Cells Transl Med. 2014 Feb;3(2):172-82. doi: 10.5966/sctm.2013-0132. Epub 2014 Jan 16.
7
Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo.
Cancer Gene Ther. 2007 Aug;14(8):756-61. doi: 10.1038/sj.cgt.7701067. Epub 2007 Jun 8.
8
Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.
J Gene Med. 2017 Mar;19(3). doi: 10.1002/jgm.2942.
9
Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
J Cancer Res Clin Oncol. 2015 Jan;141(1):75-85. doi: 10.1007/s00432-014-1763-7. Epub 2014 Aug 8.
10
Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
Cancer Res. 2004 Sep 15;64(18):6381-4. doi: 10.1158/0008-5472.CAN-04-2117.
引用本文的文献
1
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation.
Sci Rep. 2021 Aug 9;11(1):16088. doi: 10.1038/s41598-021-94573-y.
2
Oncolytic viro-chemotherapy exhibits antitumor effect in laryngeal squamous cell carcinoma cells and mouse xenografts.
Cancer Manag Res. 2019 Apr 15;11:3285-3294. doi: 10.2147/CMAR.S196304. eCollection 2019.
3
Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
Cancers (Basel). 2018 May 17;10(5):144. doi: 10.3390/cancers10050144.
4
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.
Oncotarget. 2018 Jan 3;9(4):5480-5491. doi: 10.18632/oncotarget.23869. eCollection 2018 Jan 12.
5
Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
Virology. 2016 Jan;487:249-59. doi: 10.1016/j.virol.2015.10.019. Epub 2015 Nov 9.
6
Gene therapy for cancer: present status and future perspective.
Mol Cell Ther. 2014 Sep 10;2:27. doi: 10.1186/2052-8426-2-27. eCollection 2014.
7
Oncolytic adenoviruses: A thorny path to glioma cure.
Genes Dis. 2014 Dec;1(2):214-226. doi: 10.1016/j.gendis.2014.09.009.
8
Progression of O⁶-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research.
Mol Biol Rep. 2014 Oct;41(10):6659-65. doi: 10.1007/s11033-014-3549-z. Epub 2014 Jul 3.
9
Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities.
J Mol Signal. 2013 Dec 30;8(1):15. doi: 10.1186/1750-2187-8-15.
10
The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.
Tumour Biol. 2013 Oct;34(5):3027-34. doi: 10.1007/s13277-013-0867-z. Epub 2013 Aug 2.
本文引用的文献
1
Mechanisms of chemoresistance to alkylating agents in malignant glioma.
Clin Cancer Res. 2008 May 15;14(10):2900-8. doi: 10.1158/1078-0432.CCR-07-1719.
2
Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature.
Brain Pathol. 2008 Jul;18(3):378-86. doi: 10.1111/j.1750-3639.2008.00137.x. Epub 2008 Apr 2.
3
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter.
Cancer Res. 2007 Dec 15;67(24):11499-504. doi: 10.1158/0008-5472.CAN-07-5312.
4
Self-eating and self-killing: crosstalk between autophagy and apoptosis.
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52. doi: 10.1038/nrm2239.
5
Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
J Gene Med. 2007 Mar;9(3):151-60. doi: 10.1002/jgm.1008.
6
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
Oncogene. 2007 Jan 11;26(2):186-97. doi: 10.1038/sj.onc.1209785. Epub 2006 Jul 3.
7
Gene therapy for malignant glioma: current clinical status.
Mol Ther. 2005 Oct;12(4):585-98. doi: 10.1016/j.ymthe.2005.07.357.
8
Targeting apoptosis pathways in cancer therapy.
Curr Cancer Drug Targets. 2004 Nov;4(7):569-76. doi: 10.2174/1568009043332763.
9
Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control.
Gene Ther. 2004 Aug;11(16):1296-300. doi: 10.1038/sj.gt.3302292.
10
Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
Mol Ther. 2004 Jun;9(6):818-28. doi: 10.1016/j.ymthe.2004.03.014.
Zotero 插件